Company: VREOF
Filing Date: 2025-03-21
Form Type: DEFM14C
Source: 0001140361-25-009815
Chunk: 240

Company: Vireo Growth Inc.
Filing Date: 2025-03-21
Form: DEFM14C
Chunk 240
---
umulated deficit’ balance of $5,920,261 to Additional paid-in capital; (2) reclassifying Wholesome’s ‘Series A common stock’ balance of $8,915 to Additional paid-in capital; (3) reclassifying Wholesome’s ‘Series B common stock’ balance of $8,000 to Additional paid-in capital; and (4) reclassifying Wholesome’s ‘Series B2 common stock’ balance of $386 to Additional paid-in capital. |

| C | Not used. |

| D | Not used. |

| E | Represents an assumed fair value of the contingent consideration for the potential forfeitures related to the Wholesome Forfeiture Shares, as defined below. No amount has been estimated for the Wholesome EBITDA Earn-Out Shares or the Wholesome E-Commerce Earn-Out Shares, as the accounting is expected to be finalized upon consummation of the Wholesome Merger. Refer to Note 4 for additional information related to the Wholesome Forfeiture Shares, the Wholesome EBITDA Earn-Out Shares and the Wholesome E-Commerce Earn-Out Shares. |

Adjustments to Unaudited Pro Forma Condensed Combined Statement of Operations The pro forma adjustment included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2024 is as follows:

| AA | Represents estimated remaining transaction costs not already reflected in the December 31, 2024 historical financial statements of Vireo of $1,449,636 as if incurred on January 1, 2024, the date the Wholesome Merger occurred for the purposes of the unaudited pro forma condensed combined statement of operations. The $1,126,000 of transaction costs incurred and therefore already recorded in the December 31, 2024 historical financial statements of Vireo is recorded within “Professional fees.” |

138

TABLE OF CONTENTS

Note 4. Estimated Purchase Price Consideration The estimated preliminary purchase price allocation for the Wholesome Merger and the corresponding aggregate Merger Consideration is presented in the table below as if the Wholesome Merger closed on December 31, 2024. The purchase price allocation for the proposed Wholesome Merger is preliminary and subject to revision once the proposed Wholesome Merger is complete and as additional information about the fair value of the assets to be acquired and liabilities to be assumed becomes available. In general, due to